Company or institution

Arrowhead Pharmaceuticals, Inc.

Save Like

152 applicationsfiled 2016 to 2026

Allowance rate

77%

+2 pts vs the USPTO range 69% to 84%

Rejections before allowance

1.2

−0.4 vs the USPTO

Months to first action

10.3 mo

−8.3 vs the USPTO

Needed an RCE

18%

−9 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C12N Microorganisms or enzymes77 apps

A61K Medical preparations60 apps

A61P Therapeutic activity of compounds6 apps

C07H 4 apps

C07K Peptides3 apps

C07F 1 apps

Art units

163565 apps

OPAP33 apps

167412 apps

163711 apps

16236 apps

16366 apps

Examiners met

The examiners seen most, and how it went with each

Docket Central34 apps

n/a

Jon E Angell21 apps

90%

Brian A Whiteman17 apps

76%

Amy Rose Hudson9 apps

56%

Tracy Ann Vivlemore7 apps

86%

Jane J Zara7 apps

71%

Terra C Gibbs5 apps

75%

Kimberly Chong4 apps

50%

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

Arrowhead Pharmaceuticals, Inc.58 apps

97%

Fish & Richardson P.C. (ARROWHEAD)44 apps

64%

Honigman LLP/Arrowhead Pharmaceuticals, Inc.15 apps

60%

GlaxoSmithKline11 apps

89%

Takeda Pharmaceuticals International Co.8 apps

80%

STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.5 apps

100%

AMGEN INC.4 apps

67%

WOLF GREENFIELD & SACKS, P.C.3 apps

67%

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19467047	RNAi Agents for Inhibiting Expression of Superoxide Dismutase 1 (SOD1), Composition…	2026-02-02	Pending	0	0	n/a
19448282	RNAi Agents for Inhibiting Expression of Microtubule Associated Protein Tau (MAPT),…	2026-01-14	Pending	0	0	n/a
19429847	ANTI-TRANSFERRIN RECEPTOR ANTIBODIES, CONJUGATES THEREOF, AND USES THEREOF	2025-12-22	Pending	0	0	n/a
15170943	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15166905	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15364585	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15555511	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15763899	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15271235	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15640464	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 152 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in